EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prodigiosin Enhanced TMZ Chemosensitivity by Suppressing Focal Adhesion and Inhibiting Autophagy in Glioblastoma Cells

Shihui Dai, Xin Liu, Xiangyu Jin, Shaoming Mo, Li Li, Chuan Wang, Yaomei Tian

Biomolecules · 03.07.2026 · 16 (7) · 977

DOI: 10.3390/biom16070977 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, online erschienen am 03.07.2026. Verfasst von Shihui Dai und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Food and Liquor Engineering, Sichuan University of Science & Engineering, No. 519, Huixing Road, Ziliujing District, Zigong 643000, China. Hauptthemen laut MEDLINE: Temozolomide, Glioblastoma, Autophagy, Prodigiosin. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sichuan University of Science and Engineering, Sichuan Science and Technology Program, Scientific Research Innovation Team Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma (GBM) remains a lethal brain tumor with poor prognosis and limited therapeutic efficacy from temozolomide (TMZ) treatment. Prodigiosin (PG), a bioactive secondary metabolite, has demonstrated anti-tumor activity across a broad spectrum of tumors. This study aims to investigate the therapeutic potential and mechanism of PG combined with TMZ in treating GBM. The results demonstrated that the combination of PG and TMZ synergistically inhibited GBM cell proliferation, triggered apoptosis, and suppressed migration and invasion. Transcriptomic analysis revealed downregulation of focal adhesion and related signaling pathways. Functionally, the combination therapy reduced focal adhesion numbers and AKT phosphorylation. Co-treatment with PG and TMZ impaired autophagic flux, evidenced by LC3-II and p62 accumulation. Furthermore, the anti-proliferative effect and the accumulation of LC3-II and P62 by the combination therapy were enhanced by the autophagy inhibitor chloroquine (CQ) but not reversed by the autophagy activator rapamycin (Rapa), confirming autophagy inhibition as a key mechanism. In conclusion, PG sensitized GBM cells to TMZ by impairing autophagy and focal adhesion signaling, providing a preclinical rationale for the combinatorial strategy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TemozolomideGlioblastomaAutophagyProdigiosinFocal AdhesionsBrain NeoplasmsHumansCell Line, TumorCell ProliferationApoptosisCell MovementSignal TransductionDrug Synergism

Stichwörter der Autor:innen

combinatorial strategyglioblastomaprodigiosintemozolomide

Substanzen

TemozolomideProdigiosin

Autor:innen und Institutionen

  • School of Food and Liquor Engineering, Sichuan University of Science & Engineering, No. 519, Huixing Road, Ziliujing District, Zigong 643000, China.

Förderung

  • Sichuan University of Science and Engineering
  • Sichuan Science and Technology Program
  • Scientific Research Innovation Team Program
  • Sichuan University of Science & Engineering Scientific Research Development Fund

Zitieren

APA

Dai, S., Liu, X., Jin, X., Mo, S., Li, L., Wang, C., & Tian, Y. (2026). Prodigiosin Enhanced TMZ Chemosensitivity by Suppressing Focal Adhesion and Inhibiting Autophagy in Glioblastoma Cells. Biomolecules, 16(7), 977. https://doi.org/10.3390/biom16070977

Vancouver

Dai S, Liu X, Jin X, Mo S, Li L, Wang C, et al. Prodigiosin Enhanced TMZ Chemosensitivity by Suppressing Focal Adhesion and Inhibiting Autophagy in Glioblastoma Cells. Biomolecules. 2026;16(7):977. doi:10.3390/biom16070977

BibTeX
@article{Dai2026,
  author = {Dai, Shihui and Liu, Xin and Jin, Xiangyu and Mo, Shaoming and Li, Li and Wang, Chuan and Tian, Yaomei},
  title = {Prodigiosin Enhanced TMZ Chemosensitivity by Suppressing Focal Adhesion and Inhibiting Autophagy in Glioblastoma Cells},
  journal = {Biomolecules},
  year = {2026},
  volume = {16},
  number = {7},
  pages = {977},
  doi = {10.3390/biom16070977}
}
Kostenlos starten →